BioLife Solutions, Inc.BLFSNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P10
Near historical low
vs 5Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -14.11% |
| Q3 2025 | 3.36% |
| Q2 2025 | 0.21% |
| Q1 2025 | 143.19% |
| Q4 2024 | -61.08% |
| Q3 2024 | 26.21% |
| Q2 2024 | -7.61% |
| Q1 2024 | -27.04% |
| Q4 2023 | 11.59% |
| Q3 2023 | -27.77% |
| Q2 2023 | 1.91% |
| Q1 2023 | 14.82% |
| Q4 2022 | 10.11% |
| Q3 2022 | 0.55% |
| Q2 2022 | 4.22% |
| Q1 2022 | -4.28% |
| Q4 2021 | 18.80% |
| Q3 2021 | 37.50% |
| Q2 2021 | 50.17% |
| Q1 2021 | 4.32% |
| Q4 2020 | 28.99% |
| Q3 2020 | 9.63% |
| Q2 2020 | -1.42% |
| Q1 2020 | 6.13% |
| Q4 2019 | 26.22% |
| Q3 2019 | 15.46% |
| Q2 2019 | -0.20% |
| Q1 2019 | 27.81% |
| Q4 2018 | 9.55% |
| Q3 2018 | 7.29% |
| Q2 2018 | 3.40% |
| Q1 2018 | 11.45% |
| Q4 2017 | 9.71% |
| Q3 2017 | -1.02% |
| Q2 2017 | 0.52% |
| Q1 2017 | 3.20% |
| Q4 2016 | -15.64% |
| Q3 2016 | -12.16% |
| Q2 2016 | 2.07% |
| Q1 2016 | -2.31% |